ONC
BeOne Medicines Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$350.84
−0.74%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.90
- Revenue estimate
- $1.8B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $2.05
- EPS estimate
- $1.63
- Revenue actual
- $1.7B
- Revenue estimate
- $1.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +45.6%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $422
- PT range
- $380 – $454
- Analysts
- 8
8 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $1.63 | $2.05 | Beat 25.77% | $1.7B |
| May 6, 2026 | $0.73 | $1.96 | Beat 168.49% | $1.5B |
| Feb 26, 2026 | $1.60 | $0.59 | Miss -63.38% | $1.5B |
| Nov 6, 2025 | $0.72 | $1.09 | Beat 51.39% | $1.4B |
| Aug 6, 2025 | $0.48 | $0.84 | Beat 75.00% | $1.3B |
| May 7, 2025 | -$0.71 | $1.22 | Beat 271.83% | $1.1B |
| Feb 27, 2025 | -$0.88 | -$1.43 | Miss -62.50% | $1.1B |
| Mar 30, 2024 | — | -$2.41 | — | $751.7M |
| Dec 30, 2023 | — | -$26 | — | $634.4M |
| Sep 29, 2023 | — | $2.01 | — | $781.3M |
| Mar 31, 2023 | — | -$3.34 | — | $447.8M |
| Jun 29, 2019 | — | -$1.43 | — | $243.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026